|
|
 |
|
Viewing report
|
|
|
|
Alere Inc. (ALR) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2012, Pages: 49
Alere Inc. (ALR) - Financial and Strategic SWOT Analysis Review
Summary
Alere Inc. (formerly Inverness Medical Innovations, Inc.) is a provider of innovative solutions, which enable patients to take charge of their own health at home and allow healthcare providers and payors to enhance care, prevent disease advancement and reduce healthcare costs. The company is a leading provider of near-patient monitoring tools and value-added healthcare services. Its products and services focus on cardiology, women’s health, infectious disease, oncology and toxicology. Priority markets include North America, Europe and Middle East, Asia Pacific, and Latin America and Africa.
Alere’s business strategy is to improve and develop new product ranges and maintaining the company’s financial strength. It focuses on innovations that are thoughtfully designed, based on extensive consumer insight, to meet the real needs of clinicians and professionals. It also follows a strategy of making alliance with others in the healthcare industry for ensuring development, promotion and reach of its products in other geographies. As a part of the strategy, the company has agreements with Miraculins, VitaPath Genetics, Thermo Fisher, EKF Diagnostics and Roche Diagnostics Limited among others. The company is headquartered in Massachusetts, the US.
Alere Inc. Key Recent Developments
Jan 12, 2012: Alere Maintains Exclusive Option To License Miraculins
Oct 26, 2011: Alere Reports Revenues Of $585.8m In Q3 2011
Jul 27, 2011: Alere Reports Net Revenue Of $567.2m In Q2 2011
Jun 13, 2011: Alere Maintains Exclusive Option On Miraculins’ Preeclampsia Technology
Apr 27, 2011: Alere Reports Q1 2011 Results
This comprehensive SWOT profile of Alere Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review
Hospira, Inc. (HSP) - Financial and Strategic SWOT Analysis Review
Covidien plc (COV) - Financial and Strategic SWOT Analysis Review
Syneron Medical Ltd. (ELOS) - Financial and Strategic SWOT Analysis Review
Healthpoint Biotherapeutics - Strategic SWOT Analysis Review
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
|
|
|
|
